OSR Holdings shares surge 15.82% intraday after Nasdaq extension and strategic initiatives progress.

OSR Holdings surged 15.82% intraday after announcing it received a 180-day Nasdaq extension to regain compliance with the $1.00 bid price requirement, extending the deadline to August 31, 2026. The company reiterated progress on strategic initiatives, including a potential $30 million upfront, $815 million milestone VXM01 licensing deal and a medical device platform merger. Management emphasized disciplined execution of these catalysts as a path to restoring compliance and enhancing shareholder value, with investor relations head Tim Smith highlighting the extension as operational runway for strategic maturity. The news reinforced confidence in the company’s ability to address liquidity concerns and advance near-term value drivers, directly aligning with the intraday price rebound.